215 related articles for article (PubMed ID: 23137711)
1. Protein and lipid damage in maple syrup urine disease patients: l-carnitine effect.
Mescka CP; Wayhs CA; Vanzin CS; Biancini GB; Guerreiro G; Manfredini V; Souza C; Wajner M; Dutra-Filho CS; Vargas CR
Int J Dev Neurosci; 2013 Feb; 31(1):21-4. PubMed ID: 23137711
[TBL] [Abstract][Full Text] [Related]
2. L-Carnitine supplementation decreases DNA damage in treated MSUD patients.
Mescka CP; Guerreiro G; Hammerschmidt T; Faverzani J; de Moura Coelho D; Mandredini V; Wayhs CA; Wajner M; Dutra-Filho CS; Vargas CR
Mutat Res; 2015 May; 775():43-7. PubMed ID: 25867118
[TBL] [Abstract][Full Text] [Related]
3. Investigation of inflammatory profile in MSUD patients: benefit of L-carnitine supplementation.
Mescka CP; Guerreiro G; Donida B; Marchetti D; Wayhs CA; Ribas GS; Coitinho AS; Wajner M; Dutra-Filho CS; Vargas CR
Metab Brain Dis; 2015 Oct; 30(5):1167-74. PubMed ID: 26002427
[TBL] [Abstract][Full Text] [Related]
4. Prevention of DNA damage by L-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro.
Mescka CP; Wayhs CA; Guerreiro G; Manfredini V; Dutra-Filho CS; Vargas CR
Gene; 2014 Sep; 548(2):294-8. PubMed ID: 25046137
[TBL] [Abstract][Full Text] [Related]
5. In vivo neuroprotective effect of L-carnitine against oxidative stress in maple syrup urine disease.
Mescka C; Moraes T; Rosa A; Mazzola P; Piccoli B; Jacques C; Dalazen G; Coelho J; Cortes M; Terra M; Regla Vargas C; Dutra-Filho CS
Metab Brain Dis; 2011 Mar; 26(1):21-8. PubMed ID: 21380499
[TBL] [Abstract][Full Text] [Related]
6. L-carnitine Prevents Oxidative Stress in the Brains of Rats Subjected to a Chemically Induced Chronic Model of MSUD.
Mescka CP; Rosa AP; Schirmbeck G; da Rosa TH; Catarino F; de Souza LO; Guerreiro G; Sitta A; Vargas CR; Dutra-Filho CS
Mol Neurobiol; 2016 Nov; 53(9):6007-6017. PubMed ID: 26526843
[TBL] [Abstract][Full Text] [Related]
7. Urinary biomarkers of oxidative damage in Maple syrup urine disease: the L-carnitine role.
Guerreiro G; Mescka CP; Sitta A; Donida B; Marchetti D; Hammerschmidt T; Faverzani J; Coelho Dde M; Wajner M; Dutra-Filho CS; Vargas CR
Int J Dev Neurosci; 2015 May; 42():10-4. PubMed ID: 25680940
[TBL] [Abstract][Full Text] [Related]
8. DNA damage induced by alloisoleucine and other metabolites in maple syrup urine disease and protective effect of l-carnitine.
Hauschild TC; Guerreiro G; Mescka CP; Coelho DM; Steffens L; Moura DJ; Manfredini V; Vargas CR
Toxicol In Vitro; 2019 Jun; 57():194-202. PubMed ID: 30853490
[TBL] [Abstract][Full Text] [Related]
9. Evidence that oxidative stress is increased in plasma from patients with maple syrup urine disease.
Barschak AG; Sitta A; Deon M; de Oliveira MH; Haeser A; Dutra-Filho CS; Wajner M; Vargas CR
Metab Brain Dis; 2006 Dec; 21(4):279-86. PubMed ID: 17091400
[TBL] [Abstract][Full Text] [Related]
10. Melatonin ameliorates oxidative stress and DNA damage of rats subjected to a chemically induced chronic model of Maple Syrup Urine Disease.
Wessler LB; Ise K; Lemos IC; Rezende VL; Duarte MB; Damiani AP; de Oliveira J; de Andrade VM; Streck EL
Metab Brain Dis; 2020 Aug; 35(6):905-914. PubMed ID: 32297169
[TBL] [Abstract][Full Text] [Related]
11. Investigation of L - Carnitine Concentrations in Treated Patients with Maple Syrup Urine Disease.
Kumru B; Oztürk Hismi B
J Pediatr Genet; 2019 Sep; 8(3):133-136. PubMed ID: 31406618
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain α-keto acids.
Amaral AU; Wajner M
Neurochem Int; 2022 Jul; 157():105360. PubMed ID: 35577033
[TBL] [Abstract][Full Text] [Related]
13. Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease.
Bridi R; Araldi J; Sgarbi MB; Testa CG; Durigon K; Wajner M; Dutra-Filho CS
Int J Dev Neurosci; 2003 Oct; 21(6):327-32. PubMed ID: 12927581
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress in plasma from maple syrup urine disease patients during treatment.
Barschak AG; Sitta A; Deon M; Barden AT; Dutra-Filho CS; Wajner M; Vargas CR
Metab Brain Dis; 2008 Mar; 23(1):71-80. PubMed ID: 18026828
[TBL] [Abstract][Full Text] [Related]
15. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
[TBL] [Abstract][Full Text] [Related]
16. Treatment of maple syrup urine disease: Benefits, risks, and challenges of liver transplantation.
Deon M; Guerreiro G; Girardi J; Ribas G; Vargas CR
Int J Dev Neurosci; 2023 Oct; 83(6):489-504. PubMed ID: 37340513
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic signaling pathways induced by acute administration of branched-chain amino acids in an animal model of maple syrup urine disease.
Vilela TC; Scaini G; Furlanetto CB; Pasquali MA; Santos JP; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Streck EL
Metab Brain Dis; 2017 Feb; 32(1):115-122. PubMed ID: 27510712
[TBL] [Abstract][Full Text] [Related]
18. Branched-chain amino acids (BCAA) administration increases autophagy and the autophagic pathway in brain tissue of rats submitted to a Maple Syrup Urine Disease (MSUD) protocol.
Fermo KT; da Silva Lemos I; Farias HR; Rosso MP; Effting PS; Leipnitz G; Streck EL
Metab Brain Dis; 2023 Jan; 38(1):287-293. PubMed ID: 36305998
[TBL] [Abstract][Full Text] [Related]
19. Preliminary results of PBA-loaded nanoparticles development and the effect on oxidative stress and neuroinflammation in rats submitted to a chemically induced chronic model of MSUD.
Mescka CP; de Moura Coelho D; Sitta A; Catarino F; Donida B; Rosa AP; Gonzalez EA; Pinheiro CV; Poletto F; Baldo G; Dutra-Filho CS; Vargas CR
Metab Brain Dis; 2021 Jun; 36(5):1015-1027. PubMed ID: 33620579
[TBL] [Abstract][Full Text] [Related]
20. L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders.
Ribas GS; Vargas CR; Wajner M
Gene; 2014 Jan; 533(2):469-76. PubMed ID: 24148561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
